|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 2 | 2025-01-28 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 2025-01-28 | active |
| Disorder of kidney due to diabetes mellitus | 2022-07-05 | active |
| Chronic kidney disease stage 1 | 2022-07-05 | active |
| Impacted molars | 2013-04-01 | active |
| Metabolic syndrome X | 2011-05-03 | active |
| Prediabetes | 1997-02-11 | active |
| Anemia | 1997-02-11 | active |
| Essential hypertension | 1995-01-31 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| insulin isophane human 70 UNT/ML / insulin regular human 30 UNT/ML Injectable Suspension [Humulin] | 2025-07-22 | 10 units subcutaneously before breakfast and dinner | Prediabetes | |
| Lisinopril 10 mg oral tablet | 2025-07-22 | Oral tablet | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
Allergies and Intolerances
| No known allergies or intolerances |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Medication reconciliation | 2024-10-01 | - |
| Depression screening | 2024-09-24 | - |
| Assessment of health and social care needs | 2024-09-24 | - |
| Assessment of anxiety | 2024-09-24 | - |
| 2024-09-24 | - | |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 2016-04-26 | - |
| Assessment of substance use | 2016-04-26 | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 2025-07-22 |
| SARS-CoV-2 mRNA vaccine | 2021-06-15 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 2017-12-05 |
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 2017-12-05 |
Care Plan
| Active Planned Care | Date | Reason |
|---|---|---|
| Diabetes self management plan | 1997-02-11 | Prediabetes |
| Lifestyle education regarding hypertension | 1995-01-31 | Essential hypertension (disorder) |
History of Past Illness
| Condition | Period | Status |
|---|---|---|
| Acute viral pharyngitis | 2024-09-14 – 2024-09-25 | inactive |
| Sprain of wrist | 2019-07-15 – 2019-08-13 | inactive |
| Acute bronchitis | 2017-11-24 – 2017-12-07 | inactive |
| Acute bronchitis | 2016-05-10 – 2016-05-20 | inactive |
Vital Signs
| Vital Signs | 2025-07-22 | 2025-01-28 |
|---|---|---|
| Body Height | 179.4 cm | 179.4 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 3 {score} |
| Body Weight | 90.7 kg | 89.8 kg |
| Body mass index (BMI) [Ratio] | 28.2 kg/m2 | 27.9 kg/m2 |
| Diastolic Blood Pressure | 97 mm[Hg] | 102 mm[Hg] |
| Systolic Blood Pressure | 142 mm[Hg] | 140 mm[Hg] |
| Heart rate | 88 /min | 90 /min |
| Respiratory rate | 14 /min | 12 /min |